Tianjin TEDA Biomedical Engineering Company Limited (HKG:8189)

HKG:8189 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	65.3	29.21	25.4	5.93	6.86	26.44
Trading Asset Securities	-	-	-	-	0.35	1
Cash & Short-Term Investments	131.72	29.21	25.4	5.93	7.21	27.44
Cash Growth	-29.23%	15.01%	328.02%	-17.68%	-73.73%	-22.78%
Accounts Receivable	78.81	14.61	10.82	8.78	31.87	32.08
Other Receivables	32.16	3.64	3.49	9.39	6.55	6.85
Receivables	110.97	18.25	14.31	18.16	45.11	42.87
Inventory	83.78	62.8	75.31	90.46	74	75.22
Other Current Assets	-0	79.37	118.98	75.79	66.75	63.21
Total Current Assets	326.47	189.62	233.99	190.34	193.07	208.75
Property, Plant & Equipment	71.86	75.04	98.35	112.94	132.05	138.81
Long-Term Investments	0.18	0.18	-	-	-	-
Goodwill	-	-	-	-	5.53	-
Other Intangible Assets	45.32	-	-	-	6.55	0.04
Other Long-Term Assets	0	-	0.18	-	-	-
Total Assets	443.84	264.84	332.53	303.28	337.2	347.6

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	82.53	22.3	8.93	16.11	20.72	29.53
Accrued Expenses	6.53	6.96	9.24	5.37	3.41	4.2
Short-Term Debt	-	59.22	62.84	29.91	19.39	7
Current Portion of Long-Term Debt	97.84	38.9	74.04	34.06	44	34.4
Current Portion of Leases	3.09	3.03	1.56	1.5	3.98	3.73
Current Income Taxes Payable	0.64	0.1	-	-	3.13	1.48
Current Unearned Revenue	147.38	72.99	77.75	86.53	73.56	67.71
Other Current Liabilities	67.64	48.34	44.7	43.37	50.05	43.96
Total Current Liabilities	405.66	251.83	279.07	216.84	218.25	192.02
Long-Term Debt	-	-	14.87	9.92	-	6
Long-Term Leases	7.88	8.59	8.81	10.38	35.23	39.21
Long-Term Deferred Tax Liabilities	1.51	1.69	1.34	1.56	2.56	-
Total Liabilities	416.59	262.11	304.09	238.7	256.05	237.24

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	213.39	213.39	189.45	189.45	189.45	189.45
Additional Paid-In Capital	332.27	332.27	275.32	275.32	275.32	275.32
Retained Earnings	-506.39	-516.6	-425.78	-397.98	-377.82	-347.15
Comprehensive Income & Other	-16.84	-16.84	-16.84	-16.84	-16.84	-16.84
Total Common Equity	22.43	12.22	22.15	49.95	70.11	100.78
Minority Interest	4.82	-9.49	6.29	14.63	11.04	9.58
Shareholders' Equity	27.25	2.73	28.44	64.58	81.15	110.36
Total Liabilities & Equity	443.84	264.84	332.53	303.28	337.2	347.6

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	108.81	109.74	162.12	85.76	102.61	90.34
Net Cash (Debt)	22.91	-80.53	-136.72	-79.83	-95.4	-62.9
Net Cash Growth	-68.85%	-	-	-	-	-
Net Cash Per Share	0.01	-0.04	-0.07	-0.04	-0.05	-0.03
Filing Date Shares Outstanding	2,134	2,134	1,895	1,895	1,895	1,895
Total Common Shares Outstanding	2,134	2,134	1,895	1,895	1,895	1,895
Working Capital	-79.18	-62.21	-45.07	-26.5	-25.17	16.72
Book Value Per Share	0.01	0.01	0.01	0.03	0.04	0.05
Tangible Book Value	-22.89	12.22	22.15	49.95	58.04	100.74
Tangible Book Value Per Share	-0.01	0.01	0.01	0.03	0.03	0.05
Buildings	-	93.92	92.25	91.53	90.38	75.49
Machinery	-	85.13	86.31	96.06	95.78	89.39
Construction In Progress	-	0.07	-	1.07	0.09	13.21

Data Source: S&P Global Market Intelligence Last updated: Sep 24, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 6, 2026

Data Sources Report a data error